A Look At Adaptive Biotechnologies (ADPT) Valuation After Q4 2025 Beat And New Pfizer Agreements [Yahoo! Finance]
Adaptive Biotechnologies Corporation (ADPT)
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
adhc.com
Company Research
Source: Yahoo! Finance
Why Adaptive Biotechnologies Stock Is Back in Focus Adaptive Biotechnologies (ADPT) is drawing attention after fourth quarter 2025 results topped analyst expectations, supported by its Minimal Residual Disease business and new Pfizer agreements tied to T cell receptor discovery and immune data licensing. See our latest analysis for Adaptive Biotechnologies. The fourth quarter surprise and Pfizer announcements have brought Adaptive Biotechnologies back into the spotlight, with a 19.3% 7 day share price return and a 98.3% 1 year total shareholder return contrasting with weaker 3 and 5 year total shareholder returns. If strong interest in immune medicine has your attention, it can be worth widening your watchlist to see what else is moving across 36 healthcare AI stocks With Adaptive Biotechnologies trading at US$14.81 and sitting at a sizeable discount to the average analyst price target, is the recent surge just catching up to fundamentals or is the market already pricing in
Show less
Read more
Impact Snapshot
Event Time:
ADPT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADPT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADPT alerts
High impacting Adaptive Biotechnologies Corporation news events
Weekly update
A roundup of the hottest topics
ADPT
News
- Adaptive Biotech's President Trimmed Her Position. But what Remains is worth a look [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies (ADPT) Moves 5.8% Higher: Will This Strength Last? [Yahoo! Finance]Yahoo! Finance
- Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf. [Yahoo! Finance]Yahoo! Finance
- Why are Analysts Optimistic About Adaptive Biotechnologies (ADPT)? [Yahoo! Finance]Yahoo! Finance
- TD Cowen is Bullish on Adaptive Biotechnologies Corporation (ADPT) [Yahoo! Finance]Yahoo! Finance
ADPT
Earnings
- 2/5/26 - Beat
ADPT
Sec Filings
- 4/10/26 - Form 4
- 4/10/26 - Form 4
- 4/8/26 - Form 4
- ADPT's page on the SEC website